Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 7, 2009, Pages 749-756

  Bouguen, G ^a   Trouilloud, I ^b   Siproudhis, L ^a   Oussalah, A ^b   Bigard, M A ^b   Bretagne, J F ^a   Peyrin Biroulet, L ^b  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

ADULT; AGED; ANALGESIA; ANAPHYLACTIC SHOCK; ANUS FISTULA; ANUS ULCER; ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; PERIANAL ABSCESS; PERIANAL CROHN DISEASE; PRIORITY JOURNAL; PSORIASIS; SKIN DISEASE; TOXICODERMA; TREATMENT RESPONSE; ULCER HEALING; UTERINE CERVIX DYSPLASIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; FEMALE; FISSURE IN ANO; GASTROINTESTINAL AGENTS; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; RECTAL FISTULA; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING; YOUNG ADULT;

EID: 69949152540     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04089.x     Document Type: Article

References (32)

1. Sandborn WJ, Fazio VW, Feagan BG, et al. AGA technical review on perianal Crohn's disease. Gastroenterology 2003 125 : 1508 1530.
2. Sangwan YP, Schoetz DJ Jr., Murray JJ, et al. Perianal Crohn's disease. Results of local surgical treatment. Dis Colon Rectum 1996 39 : 529 535.
3. Wolff BG, Culp CE, Beart RW Jr., et al. Anorectal Crohn's disease. A long-term perspective. Dis Colon Rectum 1985 28 : 709 711.
4. Keighley MR, Allan RN. Current status and influence of operation on perianal Crohn's disease. Int J Colorectal Dis 1986 1 : 104 107.
5. Siproudhis L, Mortaji A, Mary JY, et al. Anal lesions: any significant prognosis in Crohn's disease? Eur J Gastroenterol Hepatol 1997 9 : 239 243.
6. Williams DR, Coller JA, Corman ML, et al. Anal complications in Crohn's disease. Dis Colon Rectum 1981 24 : 22 4.
7. Fleshner PR, Schoetz DJ Jr., Roberts PL, et al. Anal fissure in Crohn's disease: a plea for aggressive management. Dis Colon Rectum 1995 38 : 1137 1143.
8. Sweeney JL, Ritchie JK, Nicholls RJ. Anal fissure in Crohn's disease. Br J Surg 1988 75 : 56 7.
9. Linares L, Moreira LF, Andrews H, et al. Natural history and treatment of anorectal strictures complicating Crohn's disease. Br J Surg 1988 75 : 653 655.
10. Plamondon S, Ng SC, Kamm MA. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies. Aliment Pharmacol Ther 2007 25 : 557 567.
11. Cat H, Sophani I, Lemann M, et al. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease. Turk J Gastroenterol 2003 14 : 121 127.
12. Stringer EE, Nicholson TJ, Armstrong D. Efficacy of topical metronidazole (10 percent) in the treatment of anorectal Crohn's disease. Dis Colon Rectum 2005 48 : 970 974.
13. Casson DH, Eltumi M, Tomlin S, et al. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease. Gut 2000 47 : 436 440.
14. Hart AL, Plamondon S, Kamm MA. Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial. Inflamm Bowel Dis 2007 13 : 245 253.
15. Hughes LE, Donaldson DR, Williams JG, et al. Local depot methylprednisolone injection for painful anal Crohn's disease. Gastroenterology 1988 94 : 709 711.
16. Brady CE III., Cooley BJ, Davis JC. Healing of severe perineal and cutaneous Crohn's disease with hyperbaric oxygen. Gastroenterology 1989 97 : 756 760.
17. Colombel JF, Mathieu D, Bouault JM, et al. Hyperbaric oxygenation in severe perineal Crohn's disease. Dis Colon Rectum 1995 38 : 609 614.
18. Wolkomir AF, Luchtefeld MA. Surgery for symptomatic hemorrhoids and anal fissures in Crohn's disease. Dis Colon Rectum 1993 36 : 545 547.
19. Peyrin-Biroulet L, Deltenre P, de Suray N, et al. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol 2008 6 : 644 653.
20. Ouraghi A, Nieuviarts S, Mougenel JL, et al. Infliximab therapy for Crohn's disease anoperineal lesions Gastroenterol Clin Biol 2001 25 : 949 956.
21. Schnitzler F, Fidder H, Ferrante M, et al. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Gut 2009 58 : 492 500.
22. Hughes LE. Clinical classification of perianal Crohn's disease. Dis Colon Rectum 1992 35 : 928 932.
23. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006 55 : 749 753.
24. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn's disease. Gastroenterology 2006 130 : 650 656.
25. Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007 5 : 1430 1438.
26. Parsi MA, Achkar JP, Richardson S, et al. Predictors of response to infliximab in patients with Crohn's disease. Gastroenterology 2002 123 : 707 713.
27. Sandborn W, Rutgeerts P, Reinisch W, et al. Sonic: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to Immunomodulators and biologic therapy. Am J Gastroenterol 2008 103 (Suppl 1 S436. [Abstract 1117].
28. Buchmann P, Keighley MR, Allan RN, et al. Natural history of perianal Crohn's disease. Ten year follow-up: a plea for conservatism. Am J Surg 1980 140 : 642 644.
29. Fidder H, Schnitzler F, Ferrante M, et al. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Gut 2009 58 : 501 508.
30. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004 350 : 876 885.
31. Colombel JF, Loftus EV Jr., Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 2004 126 : 19 31.
32. Sands BE, Blank MA, Diamond RH, et al. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study. Aliment Pharmacol Ther 2006 23 : 1127 1136.